Healthcare Sector – Insider-Handelsaktivität

Verfolgen Sie Insider-Käufe und -Verkäufe bei Healthcare-Aktien. Sehen Sie, welche Führungskräfte kaufen, die Netto-Inside-Aktivität und % des gehandelten Free Floats über 3,358 Unternehmen.
Die in diesem Screen bereitgestellten Informationen dienen nur zu Informationszwecken und stellen keine Finanzberatung dar. Wir befürworten keine spezifische Investition basierend auf diesen Kriterien.
Unternehmen
Daten
Abonnieren, um auf vollständige Daten zuzugreifen
Unternehmen Geschäftsfeld Marktkapitalisierung ($) Anzahl Insider mit Nettokäufen Nettowert gekauft ($) % des Streubesitzes gekauft % der von Insidern gehaltenen Aktien
Pharmaceuticals & Medical Research Mega (1.0tn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Mega (653.5bn) -1–5 -$10M–$100M -0–15% 0–15%
US Abbvie Inc (ABBV)
Pharmaceuticals & Medical Research Mega (500.8bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (372.3bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Mega (333.3bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (313.6bn) 0 Keine Aktivität — —
CH Novartis AG (NOVN)
Pharmaceuticals & Medical Research Mega (275.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (249.4bn) 1–5 $10M–$100M 0–15% 0–15%
Healthcare Services Mega (248.9bn) -1–5 -$10M–$100M -0–15% 0–15%
US Amgen Inc (AMGN)
Pharmaceuticals & Medical Research Mega (221.8bn) -1–5 -$1M–$10M -0–15% 0–15%
DK Novo Nordisk A/S (NOVO-B)
Pharmaceuticals & Medical Research Mega (201.4bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (190.4bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (176.0bn) -1–5 -$10M–$100M -0–15% 0–15%
US Pfizer Inc (PFE)
Pharmaceuticals & Medical Research Large (166.5bn) 1–5 $1M–$10M 0–15% 0–15%
Healthcare Services Large (155.4bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (151.1bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (130.4bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (125.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (120.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (111.4bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (107.4bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (105.5bn) -1–5 -$100M+ -0–15% 0–15%
FR Sanofi SA (SAN)
Pharmaceuticals & Medical Research Large (97.8bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (97.2bn) 0 Keine Aktivität — 15–50%
GB GSK plc (GSK)
Pharmaceuticals & Medical Research Large (92.8bn) 11–20 -$100K–$1M -0–15% 0–15%
AU CSL Ltd (CSL)
Pharmaceuticals & Medical Research Large (90.6bn) 0 Keine Aktivität — 0–15%
US Moderna Inc (MRNA)
Pharmaceuticals & Medical Research Large (90.3bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (87.3bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (79.6bn) 1–5 $10M–$100M 0–15% 15–50%
Pharmaceuticals & Medical Research Large (77.5bn) 0 Keine Aktivität — 0–15%
US Celgene Corp (CELG)
Pharmaceuticals & Medical Research Large (77.0bn) 0 Keine Aktivität — —
Healthcare Services Large (72.3bn) 0 Keine Aktivität — 0–15%
US Allergan plc (AGN)
Pharmaceuticals & Medical Research Large (63.7bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (61.1bn) 1–5 $1M–$10M 0–15% 0–15%
NL argenx SE (ARGX)
Pharmaceuticals & Medical Research Large (59.5bn) -6–10 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (59.0bn) -1–5 -$1M–$10M -0–15% 0–15%
DE Bayer AG (BAYN)
Pharmaceuticals & Medical Research Large (55.1bn) 0 Keine Aktivität — —
Pharmaceuticals & Medical Research Large (53.1bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (51.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (51.4bn) -6–10 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (50.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (50.6bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (49.4bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (48.7bn) -1–5 -< $100K -0–15% 0–15%
US Medline Inc (MDLN)
Healthcare Services Large (48.2bn) -1–5 -$100M+ -0–15% 0–15%
US Humana Inc (HUM)
Healthcare Services Large (46.5bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (44.7bn) 0 Keine Aktivität — 50%+
Pharmaceuticals & Medical Research Large (44.1bn) -6–10 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (43.8bn) -1–5 -$1M–$10M -0–15% 0–15%
BE Ucb SA (UCB)
Pharmaceuticals & Medical Research Large (43.5bn) 1–5 $100K–$1M 0–15% 15–50%
US Seagen Inc (SGEN)
Pharmaceuticals & Medical Research Large (43.2bn) 0 Keine Aktivität — 0–15%
US Waters Corp (WAT)
Healthcare Services Large (42.6bn) -1–5 -$1M–$10M -0–15% 0–15%
US Illumina Inc (ILMN)
Healthcare Services Large (41.2bn) -1–5 -$100M+ -0–15% 0–15%
Healthcare Services Large (41.1bn) -1–5 -$1M–$10M -0–15% 0–15%
GB Haleon PLC (HLN)
Pharmaceuticals & Medical Research Large (39.7bn) 1–5 < $100K 0–15% 0–15%
Pharmaceuticals & Medical Research Large (39.5bn) 0 Keine Aktivität — 0–15%
US Centene Corp (CNC)
Healthcare Services Large (34.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (33.8bn) 0 Keine Aktivität — 0–15%
US Biogen Inc (BIIB)
Pharmaceuticals & Medical Research Large (33.3bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (32.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (32.0bn) 0 Keine Aktivität — 50%+
Healthcare Services Large (31.9bn) 0 Keine Aktivität — 0–15%
US Dexcom Inc (DXCM)
Healthcare Services Large (31.5bn) 0 Keine Aktivität — 0–15%
US Resmed Inc (RMD)
Healthcare Services Large (31.0bn) 0 Keine Aktivität — 0–15%
CH Alcon AG (ALC)
Healthcare Services Large (30.8bn) 0 Keine Aktivität — 0–15%
US Zoetis Inc (ZTS)
Pharmaceuticals & Medical Research Large (28.9bn) 0 Keine Aktivität — 0–15%
US Cerner Corp (CERN)
Healthcare Services Large (27.9bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (27.6bn) -1–5 -$10M–$100M -0–15% 15–50%
Healthcare Services Large (26.8bn) 0 Keine Aktivität — 15–50%
Pharmaceuticals & Medical Research Large (26.7bn) -1–5 -$1M–$10M -0–15% 50%+
Pharmaceuticals & Medical Research Large (26.6bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (26.4bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (25.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (25.5bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (25.3bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (23.9bn) -6–10 -$10M–$100M -0–15% 0–15%
US Steris Ltd (STE)
Healthcare Services Large (23.9bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (23.2bn) 1–5 $100K–$1M 0–15% 15–50%
IE STERIS plc (STE)
Healthcare Services Large (23.2bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (23.2bn) -1–5 -$100K–$1M -0–15% 0–15%
DE Biontech SE (BNTX)
Pharmaceuticals & Medical Research Large (23.1bn) -1–5 -$10M–$100M -0–15% 50%+
US Incyte Corp (INCY)
Pharmaceuticals & Medical Research Large (22.6bn) -1–5 -$10M–$100M -0–15% 0–15%
DK Genmab A/S (GMAB)
Pharmaceuticals & Medical Research Large (22.3bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (21.7bn) -11–20 -$10M–$100M -0–15% 0–15%
US Viatris Inc (VTRS)
Pharmaceuticals & Medical Research Large (20.9bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (20.3bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (20.0bn) 0 Keine Aktivität — 0–15%
Healthcare Services Large (19.8bn) 0 Keine Aktivität — 15–50%
Pharmaceuticals & Medical Research Large (19.4bn) 0 Keine Aktivität — 50%+
Healthcare Services Large (18.4bn) 1–5 $100K–$1M 0–15% 15–50%
Healthcare Services Large (17.9bn) 0 Keine Aktivität — 50%+
US ABIOMED Inc (ABMD)
Healthcare Services Large (17.2bn) 0 Keine Aktivität — 0–15%
US Revvity, Inc. (RVTY)
Healthcare Services Large (16.9bn) 0 Keine Aktivität — 0–15%
US Hologic Inc (HOLX)
Healthcare Services Large (16.9bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Large (16.8bn) -6–10 -$100M+ -0–15% 15–50%
Healthcare Services Large (16.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (16.6bn) -1–5 -$10M–$100M -0–15% 0–15%
DE Sartorius AG (SRT)
Healthcare Services Large (16.1bn) 0 Keine Aktivität — 50%+
DK Coloplast A/S (COLO-B)
Healthcare Services Large (16.0bn) 0 Keine Aktivität — 15–50%
IN Cipla Ltd (CIPLA)
Pharmaceuticals & Medical Research Large (15.9bn) 0 Keine Aktivität — 15–50%